KPV is a tripeptide of lysine, proline and valine. It corresponds to the C-terminal three residues of alpha-melanocyte-stimulating hormone, and the research interest follows from work on that hormone's anti-inflammatory signalling in intestinal models.

Why are BPC-157 and KPV compared?

Both appear in gastrointestinal research literature, so they surface together in searches. The overlap is the model, not the molecule — they differ in origin, in length, and in the pathways proposed for each.

Does the size difference matter?

For analysis, yes. A tripeptide and a 15-mer behave differently in synthesis and in chromatography, and impurity profiles differ accordingly. It says nothing about which is more useful in a given model, but it does change what a certificate of analysis should show.

BPC-157 vs KPV — two gut-model peptides from completely different origins

6 min readUpdated 2026-10-07

BPC-157 is a 15-amino-acid sequence derived from a protein found in gastric juice, studied broadly across tendon, muscle and gastrointestinal models. KPV is a three-amino-acid sequence — lysine, proline, valine — corresponding to the C-terminal tail of alpha-melanocyte-stimulating hormone, studied mainly in models of intestinal inflammation. They overlap in research area, not in origin, size or mechanism.

These two turn up in the same searches because they turn up in the same research area. That is a weaker relationship than it looks — the models overlap, the molecules do not.

Origin and size

Side by side
	BPC-157	KPV
Length	15 amino acids	3 amino acids
Derived from	Body-protection compound, a gastric-juice protein	The C-terminal tail of alpha-melanocyte-stimulating hormone
Main research models	Tendon, ligament, muscle, gastrointestinal	Intestinal inflammation
Proposed pathways	Several, including angiogenic and nitric-oxide signalling	Anti-inflammatory signalling associated with the parent hormone

The size difference changes what documentation should show

A tripeptide is a fundamentally easier synthesis than a 15-mer, and the impurity profile reflects that. Deletion sequences — chains missing a residue — are a larger analytical concern in a longer peptide, which is precisely what a chromatogram exists to reveal.

So the same purity number does not carry the same weight for both. On a longer sequence, a percentage with no attached chromatogram is a weaker claim, because the failure modes it needs to exclude are more numerous.

Where the literature is thin

Direct comparison between the two is essentially absent from the published record.
Much of the BPC-157 work originates from a single research group; independent replication is what would strengthen it.
KPV's literature is smaller and concentrated in intestinal models, so extrapolation to other tissues is exactly that.
Both are predominantly preclinical. Animal and cell-culture results do not transfer to other contexts by default.

The compounds discussed here

BPC-157

Not sure where to startAnswer four questions and see what the research points to →

Go deeper

How to read a peptide Certificate of Analysis

Frequently asked questions

What is KPV?: KPV is a tripeptide of lysine, proline and valine. It corresponds to the C-terminal three residues of alpha-melanocyte-stimulating hormone, and the research interest follows from work on that hormone's anti-inflammatory signalling in intestinal models.
Why are BPC-157 and KPV compared?: Both appear in gastrointestinal research literature, so they surface together in searches. The overlap is the model, not the molecule — they differ in origin, in length, and in the pathways proposed for each.
Does the size difference matter?: For analysis, yes. A tripeptide and a 15-mer behave differently in synthesis and in chromatography, and impurity profiles differ accordingly. It says nothing about which is more useful in a given model, but it does change what a certificate of analysis should show.

References

Primary literature for the compounds above. Links open the record on PubMed.

BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing Sikiric P, et al. Curr Pharm Des. 2018. PMID 29998800 → · summary
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration Chang CH, et al. J Appl Physiol. 2011. PMID 21030672 → · summary
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis Xiao B, et al. Mol Ther. 2017. PMID 28456380 → · summary
Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat Cerovecki T, et al. J Orthop Res. 2010. PMID 20225319 → · summary
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation Dalmasso G, et al. Gastroenterology. 2008. PMID 18061177 → · summary
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat Novinscak T, et al. Surg Today. 2008. PMID 18668315 → · summary
Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation Krivic A, et al. J Orthop Res. 2006. PMID 16583442 → · summary
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth Staresinic M, et al. J Orthop Res. 2003. PMID 14554208 → · summary